The Latin America, Middle East and Africa Intracranial Aneurysm Market would witness market growth of 10.4% CAGR during the forecast period (2023-2030).
Regenerative medicine and tissue engineering research holds promise for developing innovative therapies for these aneurysms. Bioengineered tissue grafts, stem cell-based therapies, and gene editing technologies are being explored to repair damaged blood vessel walls, enhance vascular integrity, and promote tissue regeneration, offering potential solutions for aneurysm recurrence and long-term complications. Increasingly, multidisciplinary collaboration among neurosurgeons, interventional neuroradiologists, neurologists, radiologists, and other healthcare professionals is becoming standard practice in managing these aneurysms.
Additionally, changes in regulatory requirements and reimbursement policies may influence market dynamics and adoption rates of novel treatment modalities and medical devices for these aneurysms. Harmonization of regulatory standards and increased reimbursement coverage can drive market growth and innovation. Furthermore, biodegradable stents are emerging as a promising option for treating these aneurysms. The progressive deterioration of these stents diminishes the likelihood of enduring complications typical of permanent implants.
The expansion of the healthcare sector in the UAE means improved access to specialized medical services, including diagnosis, treatment, and management of these aneurysms. According to the International Trade Administration (ITA), in the 2022 federal budget, $17.18 billion (AED 63.066 billion) was approved for public spending, of which 7.6% is dedicated to healthcare. Hence, increasing healthcare expenditure in the region is propelling the market’s growth.
The Brazil market dominated the LAMEA Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.3 Million by 2030. The Argentina market is showcasing a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.1% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Regenerative medicine and tissue engineering research holds promise for developing innovative therapies for these aneurysms. Bioengineered tissue grafts, stem cell-based therapies, and gene editing technologies are being explored to repair damaged blood vessel walls, enhance vascular integrity, and promote tissue regeneration, offering potential solutions for aneurysm recurrence and long-term complications. Increasingly, multidisciplinary collaboration among neurosurgeons, interventional neuroradiologists, neurologists, radiologists, and other healthcare professionals is becoming standard practice in managing these aneurysms.
Additionally, changes in regulatory requirements and reimbursement policies may influence market dynamics and adoption rates of novel treatment modalities and medical devices for these aneurysms. Harmonization of regulatory standards and increased reimbursement coverage can drive market growth and innovation. Furthermore, biodegradable stents are emerging as a promising option for treating these aneurysms. The progressive deterioration of these stents diminishes the likelihood of enduring complications typical of permanent implants.
The expansion of the healthcare sector in the UAE means improved access to specialized medical services, including diagnosis, treatment, and management of these aneurysms. According to the International Trade Administration (ITA), in the 2022 federal budget, $17.18 billion (AED 63.066 billion) was approved for public spending, of which 7.6% is dedicated to healthcare. Hence, increasing healthcare expenditure in the region is propelling the market’s growth.
The Brazil market dominated the LAMEA Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.3 Million by 2030. The Argentina market is showcasing a CAGR of 11.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 10.1% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B.Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Others
- Endovascular Coiling
- Flow Diverters
- Surgical Clipping
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Intracranial Aneurysm Market by End-use
Chapter 5. LAMEA Intracranial Aneurysm Market by Type
Chapter 6. LAMEA Intracranial Aneurysm Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Methodology
LOADING...
